Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma
- 1 August 1992
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 66 (2), 337-341
- https://doi.org/10.1038/bjc.1992.266
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Abnormal serum bone gla protein levels in multiple myeloma: Crucial role of bone formation and prognostic implicationsCancer, 1990
- Radioimmunoassay of the carboxyterminal propeptide of human type I procollagenClinical Chemistry, 1990
- Glucocorticoid-Induced Osteoporosis: Pathogenesis and ManagementAnnals of Internal Medicine, 1990
- LONG-TERM EFFECTS OF PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CL2MBP) ON BONE DISEASE OF MYELOMA PATIENTS TREATED WITH CHEMOTHERAPYHematological Oncology, 1990
- The Effect of Single Oral Doses of Prednisone on the Circadian Rhythm of Serum Osteocalcin in Normal Subjects*Journal of Clinical Endocrinology & Metabolism, 1988
- Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma CellsNew England Journal of Medicine, 1987
- Locus of a histidine-based, stable trifunctional, helix to helix collagen cross-link: stereospecific collagen structure of type I skin fibrilsBiochemistry, 1987
- Serum Levels of Type I and III Procollagen Fragments in Paget's Disease of Bone*Journal of Clinical Endocrinology & Metabolism, 1984
- LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASESThe Lancet, 1983
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975